Pharmacokinetics of N-acetylcysteine are altered in patients with chronic liver disease

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 4, 1997, Pages 787-791

  Jones, A L ^a   Jarvie, D R ^a   Simpson, D ^a   Hayes, P C ^a   Prescott, L F ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030929953     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.00209.x     Document Type: Article

References (23)

1. Scheffner AL. The reduction in vitro in viscosity of mucoprotein solutions by a new mucolytic agent NAC. Ann NY Acad Sci 1983; 106: 298-310.
2. Myers C, Bonow R, Palmeri S, Jenkins J, Corden B, Locker G. A randomised controlled trial assessing the prevention of doxorubicin cardiomyopathy by NAC. Semin Oncol 1983; 10 (Suppl. 1 ): 53-5.
3. Holoye PY, Duelge J, Hansen RM, Anderson T. Prophylaxis of isosfamide toxicity with oral acetylcysteine. Semin Oncol 1983; 10 (Suppl. 1): 66-71.
4. Botta JA, Nelson LW, Wiekler JH Jr. Acetylcysteine in the prevention of cyclophosphamide-induced cystitis in rats. J Natl Cancer Inst 1973; 51: 1051-8.
5. Horowitz JD, Henry CA, Syrjanen ML, et al. Combined use of nitroglycerin and NAC in the management of unstable angina pectoris. Circulation 1988; 77 (4): 787-94.
6. Prescott LF, Illingworth RN, Critchley JAJH, Stewart MJ, Adam RD, Proudfoot AT, Intravenous NAC: the treatment of choice for paracetamol poisoning. Br Med J 1979; 2: 1097-100.
7. Harrison PM, Wendon JA, Gimson AES, Alexander GJM, Williams R. Improvement by acetylcysteine of haemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991; 324: 1852-7.
8. Keays R, Harrison PM, Wendon JA, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. Br Med J 1991; 303: 1026-8.
9. Prescott LF, Donovan JW, Jarvie DR, Proudfoot AT. The pharmacokinetics and kinetics of intravenous NAC in patients with paracetamol overdosage. Eur J Clin Pharmacol 1989; 37: 501-6.
10. Borgstroem L, Kagedal B, Paulsen O. Pharmacokinetics of NAC in man. Eur J Pharmacol 1986; 31: 217-22.
11. Lewis PA, Woodward AJ, Maddock J. High performance liquid Chromatographic assay for NAC in plasma and urine. J Pharm Sci 1984; 73: 996-8.
12. Olsson B, Johansson M, Gabrielsson J, Bolme P. Pharmacokinetics and bioavailability of reduced and oxidised NAC. Eur J Clin Pharmacol 1988; 34: 77-82.
13. Burgunder JM, Varriale A, Lauterburg BH. Effect of NAC on plasma cysteine and glutathione following paracetamol administration. Eur J Clin Pharm 1989; 36: 127-31.
14. Rodenstein D, De Coster A, Gazzaniga A. Pharmacokinetics of oral acetylcysteine: absorption, binding and metabolism in patients with respiratory disorders. Clin Pharm 1978; 3: 247-54.
15. Bonanomi L, Gazzaniga A. Toxicological, pharmacokinetic and metabolic studies on acetylcysteine. Eur J Resp Dis 1980; 61 (Suppl. 111): 45-51.
16. Sjodin K, Nilsson E, Hullberg A, Tunek A. Metabolism of NAC: some structural requirements for the deacetylation and consequences for oral bioavailability. Biochem Pharmacol 1989; 38: 3981-5.
17. Cotgreave IA, Berggren M, Jones TW, Dawson J, Moldeus P. Gastrointestinal metabolism of NAC in the rat, including an assay for sulfite in biological systems. Biopharm Drug Dispos 1987; 8: 377-86.
18. Pessayre D, Lebrec D, Descatoire V, Peignoux M, Benhamou J-P. Mechanisms for reduced drug clearance in patients with cirrhosis. Gastroenterology 1978; 74: 566-71.
19. Bray GP, Mowat C, Muir DF, Tredger JM, Williams R. The effect of chronic alcohol intake on prognosis and outcome in paracetamol overdose. Hum Exp Toxicol 1991; 10: 435-8.
20. Lauterburg BH, Velez ME. Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity. Gut 1988; 29: 1153-7.
21. Ferner R. Paracetamol poisoning - an update. Prescribers J 1993; 33: 45-50.
22. Jones AL, Bangash IH, Bouchier IAD, Haves PC. The systemic and portal haemodynamic action of N-acetylcysteine in patients with stable cirrhosis. Gut 1994; 35: 1290-3.
23. Prescott LF, Park J, Ballantyne A, Adriaenssens P, Proudfoot AT. Treatment of paracetamol poisoning with N-acetylcysteine. Lancet 1977; 2: 432-4.